The angiotensin-converting enzyme (ACE) is an important target and has broad effects in different systems, and ACE inhibitors were originally developed for the treatment of congestive heart failure, diabetic kidney disease, and hypertension management [5]. Here, ACE is linked to diabetic kidney disease.